Sabaa Pharmaceutical turns to losses in Q1

Updated 5/31/2023 11:23:00 AM
Sabaa Pharmaceutical turns to losses in Q1

Arab Finance: Sabaa International for Pharmaceutical and Chemical Industry (SIPC) incurred net losses after tax of EGP 98,021 during the first quarter (Q1) of 2023, versus net profits after tax amounting to EGP 519,720 during he same quarter a year earlier, according to a May 31st disclosure filed to the Egyptian Exchange.

Revenues rose to EGP 2.563 million during the January-March period of this year, from EGP 2.227 million during the first three months of 2022.

Sabaa is an Egypt-based company engaged in the pharmaceutical sector. The company’s generic product portfolio includes products focused on different therapeutic categories.

Related News